Science Explorer Back to mapMap
Discussion
Researcher · Sun Pharma (United States) · United States

Alan M. Mendelsohn

Alan M. Mendelsohn publishes mostly in Immunology, Rheumatology and Cardiology and Cardiovascular Medicine, on topics such as Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments and Rheumatoid Arthritis Research and Therapies.

OpenAlex
World rank
#1,204,879
of 7,710,434 ranked researchers
Rank in United States
#386,333
of 1,627,098
Works
132
Citations
5.5k
Citations per work
41.4
h-index
28
i10-index 59Top 17% in Immunology
Alan M. Mendelsohn

What does Alan M. Mendelsohn research?

Alan M. Mendelsohn's work is mostly in Medicine (45%), Immunology and Microbiology (22%).

Health Sciences: 59 works · 45.0% of their workMedicine: 59 works · 45.0% of their workRheumatology: 25 works · 18.8% of their workCardiology and Cardiovascular Medicine: 11 works · 8.2% of their workEpidemiology: 10 works · 7.4% of their workPulmonary and Respiratory Medicine: 8 works · 5.8% of their workRadiology, Nuclear Medicine and Imaging: 6 works · 4.8% of their workEverything else: 44 works · 33.0% of their workLife Sciences: 29 works · 22.0% of their workImmunology and Microbiology: 29 works · 22.0% of their workImmunology: 29 works · 22.0% of their workTHEIR WORKAlan M.Mendelsohn132works
Life Sciences22%Health Sciences45%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5945.0%
  2. Everything else4433.0%
    1. Immunology and Microbiology2922.0%
  1. 1Immunology22% of their works
  2. 2Rheumatology19% of their works
  3. 3Cardiology and Cardiovascular Medicine8% of their works
  4. 4Epidemiology7% of their works
  5. 5Pulmonary and Respiratory Medicine6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging5% of their works

Research topics

Which keywords describe Alan M. Mendelsohn's research?

The keywords of their largest research topics: IL-17, TH17 Cells, Autoantibodies, Ankylosing Spondylitis, Spondyloarthritis, Inflammation, Rheumatoid Arthritis and Cardiac Surgery.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. IL-17721 topic
  2. TH17 Cells721 topic
  3. Autoantibodies432 topics
  4. Ankylosing Spondylitis361 topic
  5. Spondyloarthritis361 topic
  6. Inflammation321 topic
  7. Rheumatoid Arthritis321 topic
  8. Cardiac Surgery211 topic
  9. Congenital Heart Disease211 topic
  10. Hemophagocytic Lymphohistiocytosis161 topic
  11. Juvenile Idiopathic Arthritis161 topic
  12. Cost-effectiveness Analysis121 topic
  13. Fc Receptors121 topic
  14. Quality of Life121 topic
  15. Therapeutic Antibodies121 topic
  16. Pemphigoid111 topic
  17. Rituximab111 topic

Where does Alan M. Mendelsohn work?

Alan M. Mendelsohn's main affiliation in the publication record is Sun Pharma (United States), United States.

How many publications and citations does Alan M. Mendelsohn have?

OpenAlex counts 132 works and 5,469 citations for Alan M. Mendelsohn, an h-index of 28, ranking #1,204,879 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Alan M. Mendelsohn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.